1. Beck AT, Mahoney M. Schools of `thought.' Am Psychol 1979;34:93–98.

2. Buysse DJ, Kupfer DJ, Frank E, Monk TH, Ritenour A, Ehlers CL. Electroenephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy. I. Baseline studies in responders and non-responders. Psychiatr Res 1992;40:13–26.

3. Buysse DJ, Kupfer DJ, Frank E, Monk TH, Ritenour A. Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy. II. Longitudinal studies at baseline and recovery. Psychiatr Res 1992;40:27–40.

4. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991;148:598–605.

5. Crits-Cristoph P, Cooper A, Luborsky L. The accuracy of therapists' interpretations and the outcome of dynamic psychotherapy. J Consult Clin Psychol 1988;56:490–495.

6. Davies MA, Conley RR, Schulz SC, Bell-Delaney J. One-year follow-up of 24 patients in a clinical trial of clozapine. Hosp Community Psychiatry 1991;42(6):628–629.

7. Dimascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klerman GL. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 1979;36:1450–1456.

8. Elkin I, Pilkonis P, Docherty J, Sotsky S. Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy. II. Nature and timing of treatment effects. Am J Psychiatry 1988;145:1070–1076.

9. Elkin I, Shea T, Watkins J, et al. NIMH treatment of depression collaborative research program: comparative outcome findings. Arch Gen Psychiatry 1989;49:971–982.

10. Frank E, Kupfer DJ. Does a placebo tablet affect psychotherapeutic treatment outcome? Results from the Pittsburgh study of maintenance therapies in recurrent depression. Psychotherapy Res 1992; 2:102–111.

11. Frank E, Jarrett DB, Kupfer DJ, Grochocinski VJ. Biological and clinical predictors of response in recurrent depression (a preliminary report). Psychiatry Res 1984;13:315–324.

12. Frank E, Prien R, Kupfer DJ. Implications of non-compliance on research in affective disorders. Psychopharmacol Bull 1985;21:37–42.

13. Frank E, Kupfer DJ, Jacob M, Jarrett D. Personality features and response to acute treatment in recurrent depression. J Pers Dis 1987;1:14–26.

14. Frank E, Kupfer DJ, Perel JM, et al. Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093–1099.

15. Frank E, Kupfer DJ, Wagner EF, McEachran A, Cornes C. Efficacy of interpersonal psychotherapy as a maintenance treatment for recurrent depression: contributing factors. Arch Gen Psychiatry 1991;48:1053–1059.

16. Frank E, Prien R, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: response, remission, recovery, relapse and recurrence. Arch Gen Psychiatry 1991;48:851–855.

17. Gibbons RD, Hedokor D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993;50:739–750.

18. Glick ID, Clarkin JF, Haas GL, Spencer JH Jr, Chen CL. A randomized clinical trial of inpatient family intervention. VI. Mediating variables and outcome. Fam Process 1991;30:85–99.

19. Greden JF, Gardner R, King D, et al. Dexamethasone suppression test in antidepressant treatment of melancholia. Arch Gen Psychiatry 1983;40:493–500.

20. Greenhouse JB, Stangl D, Kupfer DJ, Prien RF. Methodological issues in maintenance therapy clinical trials. Arch Gen Psychiatry 1991;48:313–318.

21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.

22. Hogarty GE, Schooler NR, Ulrich RF, Mussare F, Herron E, Ferro P. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 1979;36:1283–1294.

23. Hogarty GE, Anderson CM, Reiss DJ, et al. Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986;43:633–642.

24. Hogarty GE, Anderson CM, Reiss DJ, et al. Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia. Arch Gen Psychiatry 1991; 48:340–347.

25. Hollon S, Beck AT. Psychotherapy and drug therapy: comparisons and combinations. In: Garfield SL, Bergin AE, eds. Handbook of psychotherapy and behavior change: an empirical analysis, 2nd ed. New York: Wiley, 1978;437–490.

26. Hugdahl K, Ost L. On the difference between statistical and clinical significance. Behav Assess 1981;3:289–295.

27. Jacob M, Frank E, Kupfer DJ, Cornes C, Carpenter LL. A psychoeducational workshop for depressed patients, family and friends: description and evaluation. Hosp Community Psychiatry 1987; 38:968–972.

28. Jacobson NS, Follette WC, Revenstorf D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance. Behav Ther 1984;15:336–352.

29. Karp JF, Frank E, Anderson B, et al. Time to remission in late-life depression: analysis of effects of demographic, treatment, and life-events measures. Depression 1993;1:250–256.

30. Kasdin AE. Comparative outcomes studies of psychotherapy: methodological issues and strategies. J Consult Clin Psychol 1986; 54:95–105.

31. Kavanagh DJ. Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992;160:601–620.

32. Kupfer DJ, Frank E, Grochocinski VJ, Messiano M, McEachran AB. EEG sleep profiles in recurrent depression: a longitudinal investigation. Arch Gen Psychiatry 1988;45:678–681.

33. Kupfer DJ, Frank E, Grochocinski VJ, McEachran AB. Delta sleep ratio: a biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 1990;47:1100–1105.

34. Langer G, Konig G, Hatzinger R, et al. Response of thyrotropin to thyrotropin-releasing hormone as a predictor of treatment outcome: prediction of recovery and relapse in treatment with antidepressants and neuroleptics. Arch Gen Psychiatry 1986;43:861–868.

35. Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R. Should chronic treatment refractory akathisia be an indication for the use of clozapine in schizophrenic patients? J Clin Psychiatry 1992;53(7):248–251.

36. Luborsky L, McLellan AT, Woody GE, O'Brien CP, Auerbach A. Therapist success and its determinants. Arch Gen Psychiatry 1985;42:602–611.

37. Mavissakalian M, Michelson L. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatry 1986;47:117–122.

38. Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41(8):892–897.

39. Michelson L, Mavissakalian M. Psychophysiological outcome of behavioral and pharmacologic treatments of agoraphobia. J Consult Clin Psychol 1985;53:229–236.

40. Michelson L, Mavissakalian M, Marchione K. Cognitive-behavioral treatment of agoraphobia: clinical, behavioral, and psychophysiological outcome. J Consult Clin Psychol 1985;53:913–925.

41. Michelson L. Treatment consonance and response profiles in agoraphobia: the role of individual differences in Cancelede, behavioral and physiological treatments. Behav Res Ther 1986;24:263–275.

42. Miklowitz DJ, Goldstein MJ. Behavioral family treatment for patients with bipolar affective disorder. Special Issue: Recent developments in the behavioral treatment of chronic psychiatric illness. Behav Mod 1990;14:457–589.

43. O'Leary KD, Borkovec TD. Conceptual, methodological and ethical problems of placebo groups in psychotherapy research. Am Psychol 1978;Sept:821–830.

44. O'Malley SS, Foley SH, Rounsaville BJ, et al. Therapist competence and patient outcome in interpersonal psychotherapy of depression. J Consult Clin Psychol 1988;56:496–501.

45. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799–812.

46. Parloff MB. Placebo controls in psychotherapy research: a sine qua non or a placebo for research problems? J Consult Clin Psychol 1986;54(1):79–87.

47. Pilkonis PA, Frank E. Personality pathology in recurrent depression: nature, prevalence, and relationship to treatment response. Am J Psychiatry 1988;145(4):435–441.

48. Prien R, Carpenter LL, Kupfer DJ. The definition and operational criteria for treatment outcome of major depressive disorder: a review of the current research literature. Arch Gen Psychiatry 1991; 48:796–800.

49. Robins LN, Helzer JE, Croughan JL. The NIMH diagnostic interview schedule (DIS). St Louis: Washington University, 1979.

50. Rush AJ, Beck AT, Kovacs M, Hollon S. Comparative efficacy of cognitive therapy and imipramine in the treatment of depressed outpatients. Cognitive Ther Res 1977;1:17–37.

51. Rush AJ, Hollon SD. Clinical implications of research into specific disorders: depression. In: Beitman BD, Klerman GL, eds. Integrating pharmacotherapy and psychotherapy. Washington, DC: American Psychiatric Press, 1991;121–142.

52. Simons AD, Thase ME. Biological markers: treatment outcome and one-year follow-up of endogenous depression. Electroencephalographic sleep studies in response to cognitive therapy. J Consult Clin Psychiatry 1992;60:392–401.

53. Spitzer RL, Endicott J. Schedule for affective disorders and schizophrenia. New York: New York State Psychiatric Institute, 1975.

54. Spitzer RL, Endicott J, Robbins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:733–782.

55. Spitzer RL, Williams JBW, Gibbon M, First MB. The structured clinical interview for DSM-III-R, I: history, rationale and description. Arch Gen Psychiatry 1992;49:624–629.

56. Thase ME, Simons AD, Cahalane J, McGeary J. Cognitive behavior therapy of endogenous depression, part 1: an outpatient clinical replication series. Behav Ther 1991;22:457–467.

57. Waskow IE, Parloff MB. Psychotherapy change measures. Washington, DC: Department of Health, Education, and Welfare, 1975.

58. Weissman MM, Klerman GL, Paykel ES, Prusoff BA, Hanson B. Treatment effects on the social adjustments of depressed patients. Arch Gen Psychiatry 1974;30:771–778.

59. Weissman MM, Prusoff BA, DiMascio A, Neu C, Goklaney M, Klerman GL. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979;136:555–558.

60. Yeaton WH, Sechrest L. Critical dimensions in the choice and maintenance of successful treatments: strength, integrity and effectiveness. J Consult Clin Psychol 1981;49:156–167.